Suppr超能文献

血管内动脉瘤囊内栓塞治疗血管内修复后ⅠA型内漏的效果。

Effectiveness of Intra-Arterial Aneurysm Sac Embolization for Type Ia Endoleak after Endovascular Aneurysm Repair.

机构信息

Clinic of Vascular and Endovascular Surgery, University of Münster, Albert-Schweitzer Campus 1, 48145 Muenster, Germany.

Clinic of Vascular and Endovascular Surgery, University of Münster, Albert-Schweitzer Campus 1, 48145 Muenster, Germany.

出版信息

J Vasc Interv Radiol. 2019 Apr;30(4):531-538. doi: 10.1016/j.jvir.2018.11.028. Epub 2019 Mar 15.

Abstract

PURPOSE

To evaluate the effectiveness and durability of intra-arterial aneurysm sac embolization for the treatment of type Ia endoleak after endovascular aneurysm repair (EVAR).

MATERIALS AND METHODS

From February 2011 to December 2016, 22 patients underwent embolization of a type Ia endoleak after EVAR. Four patients (18%) were treated during the index EVAR and 18 (82%) in follow-up. Five patients (23%) were treated urgently and 17 (77%) electively. The embolization was performed with the use of liquid embolic agent, coils, and/or plugs. Adjunctive neck procedures were performed in 55% (n = 12) of the patients. The primary endpoint of this study was freedom from sac enlargement. Key secondary endpoints were technical success and freedom from endoleak-related reinterventions.

RESULTS

Technical success was 100%. The 30-day mortality was 5% (n = 1; acute coronary syndrome). At a mean follow-up of 15.4 months (range 0.1-65.4) the freedom from sac enlargement rate was 76% (16 out of 21). Reintervention-free survival rates at 6, 12, and 24 months were 80%, 68% and 68%, respectively.

CONCLUSIONS

In patients with persistent type Ia endoleak the embolization of the aneurysm sac with or without adjunctive neck procedures can be safely performed, leading to acceptable clinical and radiologic outcomes.

摘要

目的

评估血管内动脉瘤修复术(EVAR)后腔内治疗 I 型内漏的疗效和持久性。

材料和方法

2011 年 2 月至 2016 年 12 月,22 例患者接受了 EVAR 后 I 型内漏的栓塞治疗。4 例(18%)在指数 EVAR 期间治疗,18 例(82%)在随访中治疗。5 例(23%)为紧急治疗,17 例(77%)为择期治疗。栓塞采用液体栓塞剂、线圈和/或塞子进行。55%(n=12)的患者行附加颈部手术。本研究的主要终点是无瘤腔扩大。主要次要终点是技术成功和无内漏相关再干预。

结果

技术成功率为 100%。30 天死亡率为 5%(n=1;急性冠状动脉综合征)。平均随访 15.4 个月(0.1-65.4),瘤腔无扩大率为 76%(21 例中有 16 例)。6、12 和 24 个月的无再干预生存率分别为 80%、68%和 68%。

结论

对于持续性 I 型内漏患者,瘤腔栓塞联合或不联合附加颈部手术可安全进行,可获得可接受的临床和影像学结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验